Physical Stress Echocardiography Evaluation in Athletes with Bicuspid Aortic Valves

Laura Stefani, Roberto Mercuri, Gabriele Innocenti, Loira Toncelli, Maria Concetta Robertina Vono, Giorgio Galanti

.

DOI: 10.4236/ijcm.2010.11005                

Abstract

Objective: Bicuspid Aortic Valve (BAV) is normally asymptomatic for a long time in both the general population and regularlytrained athletes. The study aimed to evaluate the role of physical stress echocardiography in early identification of any possible dissimilarities in the Left Ventricle (LV) performance and the valve functioning of asymptomatic BAV athletes as compared to the Tricuspid Aortic Valve (TAV) athletes. Design: Data were collected for BAV and TAV athletes from echocardographic examinations to evaluate any possible differences between them. Setting: Sport Medicine Center University of FlorenceItaly. Participants: 66 male BAV athletes and 45 TAV athletes Assessment of risk factors: decrease in LV performance and aortic valve dysfunction during stress test. Main outcome measures: Measure of the standard echocardiographic parameters. Comparison of LV Ejection Fraction (EF) and Aortic Peak Flow Velocity (APFV) data in the two groups at rest and after stress. Results: At rest, values were normal in both groups, although LV systolic diameters tended to be higher in BAV. After physical effort, APFV and EF showed a significant increase in both groups, and for the former the values were at the upper limits in BAV (2.55 m/s BAV 2.12 m/s TAV). Conclusions: The data confirm normal LV performance in asymptomatic BAV athletes. Considering the tendency of this group to show slight enhancement of both APFV and LV dimensions in this group periodical evaluation with physical stress echography might be proposed as a followup procedure for early detection of any additional effect of physical exercise.

Keywords

Bicuspid Aortic Valve, Physical Stress Echography, Athletes

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	P. W. M. Fedak, S. Verna and T. E. J. David, “Clinical and Pathophysiological Implications of Bicuspid Aortic Valve,” Circulation, Vol. 106, No. 8, August 2002, pp. 900904.
[2]	L. Stefani, G. Galanti, L. Toncelli, et al., “Bicuspid Aortic Valve in Competitive Athletes,” British Journal of Sports Medicine, Vol. 42, No. 1, January 2008, pp. 3135.
[3]	R. S. Beroukim, T. L. Kruzic, A. L. Taylor, et al., “Progression of Aortic Dilatation in Children with a Functionally Normal Bicuspid Aortic Valve,” American Journal of Cardiology, Vol. 98, No. 6, September 2006, pp. 828830.
[4]	G. Galanti, L. Stefani, L. Toncelli, et al., “Effects of Sport Activity in Athletes with Bicuspid Aortic Valve and Mild Aortic Regurgitation,” British Journal of Sports Medicine, Vol. 44, No. 4, March 2010, pp. 275279.
[5]	P. W. Fedak, M. P. L. de Sa and S. Verna, “Vascular Matrix Remodeling in Patients with Bicuspid Aortic Valve Malformation Implication for Aortic Dilatation,” Journal of Thoracic and Cardiovascular Surgery, Vol. 126, No. 3, September 2003, pp. 797806.
[6]	S. A. le Marie, X. Wang and J. A. Wilks, “Matrix Metalloproteinases in Ascending Aortic Aneurysm Bicuspid Versus Trilefted Aortic Valves,” Journal of Surgical Research, Vol. 123, No. 1, 2005, pp. 4048.
[7]	E. Picano, “Stress Echocardiography,” Expert Review of Cardiovascular Therapy, Vol, 2, No. 1, January 2004, pp. 7788.
[8]	C. S. Jr. Sidney, “ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease,” Journal of the American College of Cardiology, Vol. 48, No. 3, May 2006, pp. e1148.
[9]	J. H. Mitchell, W. Haskell, P. Snell, et al., “Task Force 8: Classification of Sport,” Journal of the American College of Cardiology, Vol. 45, No. 8, April 2005, pp. 13641367.
[10]	M. S. Fernandez, S. P. Sanders, P. Khairy, et al., “Morphology of Bicuspid Aortic Valve in Children and Adolescents,” Journal of the American College of Cardiology, Vol. 44, No. 9, October 2004, pp. 16481651.
[11]	M. D. Cheitilin, W. F. Armstrong and G. R. Aurigemma, “ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: A Report of the American College of Cardiology, American Heart Association Task Force on Practice Guidelines,” Journal of the Ame rican Society of Echocardiography, Vol. 16, No. 10, October 2003, pp. 10911110.
[12]	R. B. Devereux, “Detection of Left Ventricular Hypertro phy by MMode Echocardiography. Anatomic Validation, Standardization and Comparison to Other Methods,” Hypertension, Vol. 9, No. 2, February 1987, pp. 11191126.
[13]	W. H. Gaasch, “Left Ventricular Radius to Wall Thickness Ratio,” American Journal of Cardiology, Vol. 43, No. 6, June 1979, pp. 11891194.
[14]	R. L. Popp, “MMode Echocardiographic Assessment of Left Ventricular Function,” American Journal of Cardiology, Vol. 49, No. 5, April 1982, pp. 13121318. R. Emmanuel, R. Withers and K. O’Brien, “Congenitally Bicuspid Aortic Valves, Clinicogenetic Study of 41 Families,” British Regional Heart Study, Vol. 40, No. 3, December 1978, pp. 14201427.
[15]	P. de Mozzi, U. G. Longo, G. Galanti and N. Maffulli, “Bicuspid Aortic Valve: A Literature Review and its Impact on Sport Acitivity,” British Medical Bulletin, Vol. 85, No. 1, February 2008, pp. 6385.
[16]	C. Tribouilloy, F. Lévy, D. Rusinaru, et al., “Outcome after Aortic Valve Replacement for LowFlow/Low Gradient Aortic Stenosis without Contractile Reserve on Dobutamine Stress Echocardiography,” Journal of the American College of Cardiology, Vol. 53, No. 20, May 2009, pp. 18651873.
[17]	C. Bolcal, S. Doganci, O. Baysan, et al., “Evaluation of Left Ventricular Function after Aortic Valve Replacement in a Specific Young Male Patient Population with Pure Aortic Insufficiency or Stenosis: 5 Years Followup,” Heart Surgical Forum, Vol. 10, No. 1, February 2007, pp. 5763.
[18]	M. L. Brown, H. V. Schaff, R. M. Suri, et al., “Index of Left Ventricular Dimensions Best Predict Survival after Aortic Valve Replacement in Patients with Aortic Valve Regurgitation,” Annals of Thoracic Surgery, Vol. 87, No. 4, April 2009, pp. 11611169.